ArticleJournal of translational autoimmunity2025
Matrix remodeling-associated protein 5 as a novel biomarker for predicting disease activity and endoscopic response to infliximab in Crohn's disease.
Daopo Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.